The utility of syndecan-1 circulating levels as a biomarker in patients with previous or active COVID-19: a systematic review and meta-analysis

MLA

Elina Ghondaghsaz, et al. “The Utility of Syndecan-1 Circulating Levels as a Biomarker in Patients with Previous or Active COVID-19: A Systematic Review and Meta-Analysis.” BMC Infectious Diseases, vol. 23, no. 1, Aug. 2023, pp. 1–12. EBSCOhost, https://doi.org/10.1186/s12879-023-08473-9.

APA

Elina Ghondaghsaz, Amirmohammad Khalaji, Mitra Norouzi, Douglas D. Fraser, Sanam Alilou, & Amir Hossein Behnoush. (2023). The utility of syndecan-1 circulating levels as a biomarker in patients with previous or active COVID-19: a systematic review and meta-analysis. BMC Infectious Diseases, 23(1), 1–12. https://doi.org/10.1186/s12879-023-08473-9

Chicago

Elina Ghondaghsaz, Amirmohammad Khalaji, Mitra Norouzi, Douglas D. Fraser, Sanam Alilou, and Amir Hossein Behnoush. 2023. “The Utility of Syndecan-1 Circulating Levels as a Biomarker in Patients with Previous or Active COVID-19: A Systematic Review and Meta-Analysis.” BMC Infectious Diseases 23 (1): 1–12. doi:10.1186/s12879-023-08473-9.